News
Deliveroo is set for a multi-billion dollar buyout from a takeaway rival
Their European reach is stretching even further.
UK takeaway service Deliveroo is set for a massive takeover by a fellow delivery business rival, said to be worth several billion.
The British multinational is known nationwide, occupying one of the biggest market shares alongside competitors Just Eat and Uber Eats, but now the takeaway delivery service is set to be swallowed up by an even bigger brand based in the US.
As reported on Tuesday, 6 May, American delivery firm DoorDash – the biggest of its kind in the States – looks set to complete an estimated £2.9 billion buyout, which will see Deliveroo folded into their growing global portfolio.
This massive deal will see the company’s presence in more than 40 countries further consolidated, already serving somewhere in the region of 50 million customers every month.
According to the likes of Reuters, Bloomberg and BBC, DoorDash is offering 180p per share, which is a 44% increase on Deliveroo’s share price from the point when initial takeover talks were made public in April 2025.
Speaking in a joint statement on the impending buyout, the two firms said: “The combination with Deliveroo will strengthen DoorDash’s position as a leading global platform in local commerce.”
Founded by chief executive Will Shu back in 2013, Deliveroo is now considered one of the big three in the food delivery industry’s UK scene, but is set to get much bigger under the DoorDash umbrella.
As for DoorDash, CEO and co-founder Tony Xu went on to add: “Coming together with teams that have similar visions and values accelerates our work to achieve that mission. Deliveroo is just such a team and one that I have long admired.
“Like DoorDash, Deliveroo is obsessively focused on their customers – consumers, merchants, and riders. They work day in and day out to improve their consumer value proposition, bring new services to local businesses, and offer flexibility and support to riders.”
Read more:
This isn’t the only big move they’ve made even just this week; in fact, the giant not only purchased Deliveroo but also New York’s restaurant technology company, SevenRooms Inc., which means they have forked out over $5bn in roughly five hours.
Put simply, this seriously big business and even bigger money that could make a big impact on UK hospitality and culinary convenience.
Obviously, full ratification via the SEC and so on is yet to be announced, but it looks like pretty much a done deal already.
So yeah, be prepared to see the name DoorDash being advertised up and down the country a lot more moving forward.
For all the latest news, events and goings on in Greater Manchester, subscribe to The Manc newsletter HERE.
Featured Images — @shopblocks/Focal Foto (via Flickr)
News
New endometriosis pill helping hundreds of women with ‘debilitating’ condition to be made available on NHS
Emily Sergeant
A groundbreaking new pill to help women with a ‘debilitating’ condition is set to be made available on the NHS.
The new daily pill for endometriosis – which has been approved for use on the NHS in England by the National Institute for Health and Care Excellence (NICE) – is called linzagolix, and will be available for those who have had previous treatment for endometriosis, working to manage any symptoms they may be experiencing.
Around 1.5 million women in the UK are thought to be currently living with endometriosis.
Endometriosis can cause chronic pain, heavy periods, and extreme tiredness when tissue similar to the womb lining grows elsewhere in the body.
As mentioned, linzagolix will be available specifically for patients whose previous medical or surgical treatments for endometriosis have been unsuccessful, and will be given alongside ‘add-back’ hormone therapy – which involves using low-dose hormone replacement therapy (HRT) to prevent menopause-like symptoms and bone loss.
This is the second take-at-home treatment to be approved to treat endometriosis on the NHS, and it’s thought that more than 1,000 women will benefit.
In clinical trials, linzagolix was shown to be successful in reducing painful periods and non-menstrual pelvic pain, compared with placebo, hence why it has been approved on the NHS by NICE.
“This is welcome news for women with endometriosis who haven’t found relief from previous therapies or surgery,” commented Dr Sue Mann, who is the National Clinical Director in Women’s Health for NHS England.
Read more:
“It’s another treatment option which will help women take control of their health and better manage the symptoms of this often painful and debilitating condition.
“This is a testament to our ongoing commitment to improving treatment, care and quality of life for women.”
Featured Image – Heute
News
Wigan woman jailed after hitting pedestrian in Fiat 500 while driving high on nitrous oxide ‘balloons’
Emily Sergeant
A young woman from Wigan has been handed jail time after hitting a pedestrian while driving high on nitrous oxide.
Louisa Tunstall was driving a white Fiat 500 towards the East Lancashire Road in Wigan at around 7pm on Friday 24 May 2024 – a time when traffic conditions were said to be ‘quiet’ – but Tunstall was under the influence of a now-banned drug, nitrous oxide, at the time of the incident, Greater Manchester Police (GMP) confirmed.
While driving under the influence, 19-year-old Tunstall veered to the left onto the pavement and collided with a 51-year-old woman pedestrian.
After striking the woman, the car then overturned and, in the process, caused serious life-changing injuries.
When questioned by police, Tunstall stated that she ‘took her eyes off the road’ to retrieve something in the footwell before knowing the car had flipped, but she also confirmed that she had just been out to purchase nitrous oxide to use that evening.
After obtaining witness accounts, investigating officers were able to track down nearby CCTV footable which showed Tunstall inhaling nitrous oxide through a balloon whilst driving, seconds before the collision occurred.
Further investigation by GMP’s Forensic Vehicle Examination Unit examined the Fiat 500 and confirmed that no defects were found on the car to contribute towards the collision.
Still to this day, the victim says she is trying to recover from the injuries sustained to her leg that will prevent her from continuing life as she did before.
“The incident is still very raw when I think about it,” the victim explained in her impact statement released by GMP. “I become upset when I think at everything which has been taken away from me and the ongoing affect it has had and continues to have on my daily life.”
GMP says it’s seeing the use of nitrous oxide being a factor in incidents they attend increasing year on year.
Nitrous oxide, also known as ‘laughing gas’, is reported to produce euphoria, relaxation, dizziness, giggling or laughing fits, impaired judgement, and occasionally dissociation and hallucinations – which GMP says affects reaction time and and is ‘likely lead to impairment’ in driving performance, particularly when faced with an unexpected or hazardous situation.
Read more:
Tunstall appeared at Bolton Crown Court this week, and has been sentenced to one year and eight months imprisonment for having possession of a Class C drug, driving under the influence of drugs, and causing serious injury by dangerous driving.
Alongside being jailed, she was also disqualified from driving for two years and eight months, and has been ordered to take an extended test when she is released.
Featured Image – GMP
Danny Jones -
6th May 2025 
